The USER Study: A Chart Review of Patients Receiving a 0.2 µg/day Fluocinolone Acetonide Implant for Diabetic Macular Edema

The USER Study: A Chart Review of Patients Receiving a 0.2 µg/day Fluocinolone Acetonide Implant for Diabetic Macular Edema

Abstract Introduction To determine anatomical, functional, and intraocular pressure (IOP) responses to diabetic macular edema (DME) treatments pre- and post-0.2 µg/day fluocinolone acetonide (FAc) implant administration compared with baseline and the preceding 3 years. Methods This was a retrospecti...

Full description

Bibliographic Details
Main Authors: Alexander Eaton, Sean S. Koh, Jaime Jimenez, Christopher D. Riemann
Format: Article
Language:English
Published: Adis, Springer Healthcare 2018-12-01
Series:Ophthalmology and Therapy
Subjects:
Diabetic macular edema
Fluocinolone acetonide
Intravitreal corticosteroid
Intravitreal implant
Treatment burden
Treatment frequency
Online Access:http://link.springer.com/article/10.1007/s40123-018-0155-5

Internet

http://link.springer.com/article/10.1007/s40123-018-0155-5

Similar Items